Close Menu

NEW YORK (360Dx) – PerkinElmer announced late Wednesday that it has received 510(k) clearance from the US Food and Drug Administration for two assays developed by its Euroimmun subsidiary for the screening and diagnosis of anti-neutrophil cytoplasmic antibodies (ANCA)- associated vasculitis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.